Background. Thrombotic thrombocytopenic purpura is an uncommon disease with a high
mortality rate even with current treatment. The cause of the syndrome and its optimal treatment …

The current established treatment of thrombotic thrombocytopenic purpura (TTP) is plasma
exchange with fresh frozen plasma (FFP). With this treatment, there is a 49% response after …

By use of the continuous-flow blood-cell separator 137 bags of granulocyterich plasma were
obtained from normal donors (59 bags) and patients with chronic granulocytic leukæmia (…

Thrombotic thrombocytopenic purpura is an uncommon disorder that requires prompt recognition
and intervention to prevent death. To date, information regarding the classic laboratory …

Two patients with Waldenström's macroglobulinemia (WM), which had become resistant to
cytotoxic drugs, were treated for features of the hyperviscosity syndrome by repeated plasma …

A patient developed severe post‐transfusion purpura (PTP) following transfusion of two units
of packed red blood cells. The timing of the patient's thombocytopenia suggested passive …

Intensive leukapheresis has been used as the initial treatment of chronic granulocytic leukemia
(CGL) in six patients. The number of leukaphereses ranged from 3 in 7 days to 13 in 39 …

Considerable work has been carried out over the past 25 years to define the conditions for
application of plasmapheresis or plasma exchange. The use of plasma exchange in …

A combination of eight cytotoxic drugs, administered simultaneously, has been used in 86
cases of acute leukemia. The regimen, designated TRAMPCOL, incorporated thioguanine, …

We performed an anonymous seroprevalence survey of human immunodeficiency virus (HIV)
type 1 infection through HIV antibody testing of blood samples from 22,512 women aged …